Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas
复制标题

DOI:
10.1111/j.1349-7006.2009.01385.x
复制
发表时间:
2010-01-01
期刊:
影响因子:
5.7
通讯作者:
Yaegashi, Nobuo
Yaegashi, Nobuo
中科院分区:
医学2区
文献类型:
--
作者:
Hiroki, Eri;Akahira, Jun-ichi;Yaegashi, Nobuo

文献摘要

被引文献

相似文献

本研究旨在确定子宫内膜浆液性腺癌中microRNAs (miRNAs)的表达谱,并研究miRNA表达与临床结果之间的关系。在2001年1月至2006年12月期间,21名诊断为子宫内膜浆液性腺癌的患者被纳入研究。采用miRNA芯片和qRT-PCR检测miRNA表达谱。miRNA表达水平与临床病理变量和生存率相关。与正常子宫内膜相比,子宫内膜浆液性腺癌中共有120种mirna差异表达。其中,54个mirna下调(> 2倍),包括miR-101、miR-10b*、miR-152和miR-29b,其余的上调(> 2倍),包括miR-200a、miR-200b和miR-205。miR-10b*、miR-29b、miR-455-5p的表达降低与血管侵袭相关(P = 0.048、P = 0.013、P = 0.032)。单因素分析显示,miR-101、miR-10b*、miR-139-5p、miR-152、miR-29b和miR-455-5p的低表达与总生存期差显著相关(P < 0.05), miR-152、miR-29b和miR-455-5p的低表达与无病生存期差显著相关(P < 0.05)。多因素分析显示,miR-152表达降低(P = 0.021)是影响总生存的独立危险因素,miR-101表达降低(P = 0.016)和miR-152表达降低(P = 0.010)是影响无病生存的独立危险因素。此外,转染miR-101或miR-152前体到子宫内膜浆液性癌细胞系中可以抑制细胞生长(P < 0.0001和P = 0.01)。此外,环氧化酶-2 (COX-2)的强阳性免疫反应性与miR-101的下调显著相关(P = 0.035)。这些发现提示mirna的失调与子宫内膜浆液性腺癌患者预后不良有关。(癌症科学2009)。
This study aimed to determine the expression profiles of microRNAs (miRNAs) in endometrial serous adenocarcinoma and to examine the association between miRNA expression and clinical outcomes. Twenty-one patients diagnosed with endometrial serous adenocarcinoma between January 2001 and December 2006 were enrolled. miRNA expression profiles were examined using miRNA microarray and qRT-PCR. miRNA expression levels were correlated with clinicopathological variables and survival rates. A total of 120 miRNAs were differentially expressed in endometrial serous adenocarcinoma compared to normal endometria. Of these, 54 miRNAs were down-regulated (> 2-fold), including miR-101, miR-10b*, miR-152, and miR-29b, and the remainder were up-regulated (> 2-fold), including miR-200a, miR-200b, and miR-205. Decreased expression of miR-10b*, miR-29b, and miR-455-5p was correlated with vascular invasion (P = 0.048, P = 0.013, and P = 0.032, respectively). Univariate analysis revealed that lower expression of miR-101, miR-10b*, miR-139-5p, miR-152, miR-29b, and miR-455-5p was significantly correlated with poor overall survival (P < 0.05), and reduced expression of miR-152, miR-29b, and miR-455-5p was significantly correlated with poor disease-free survival (P < 0.05). Multivariate analysis demonstrated that decreased expression of miR-152 (P = 0.021) was a statistically independent risk factor for overall survival, and decreased expression levels of miR-101 (P = 0.016) and miR-152 (P = 0.010) were statistically independent risk factors for disease-free survival. In addition, transfection of miR-101 or miR-152 precursors into an endometrial serous carcinoma cell line inhibited cell growth (P < 0.0001 and P = 0.01, respectively). Moreover, strong positive immunoreactivity of cyclooxygenase-2 (COX-2) was significantly correlated with down-regulation of miR-101 (P = 0.035). These findings suggest that the dysregulation of miRNAs is associated with the poor prognosis in endometrial serous adenocarcinoma patients. (Cancer Sci 2009).